Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025BMC Pulmonary MedicineOpen Access

Diagnostic efficacy of Mycoplasma pneumoniae antibody and procalcitonin in children with Mycoplasma pneumonia

View Full Paper
Ask AI
Bookmark
Share

Authors

ZZZhe ZhangBWBoying WuQWQijun Wang

Discussion

Loading...

Member takes

Overview

Retrospective analysis identifies MP antibody and procalcitonin as diagnostic markers in pediatric cases, suggesting their clinical utility.

Key Points

  • MP antibody and procalcitonin levels significantly improve diagnostic accuracy for mycoplasma pneumonia in children, enhancing detection rates.
  • ROC analysis shows AUCs of 0.700 for MP antibody and 0.779 for procalcitonin, with a combined AUC of 0.869, indicating strong diagnostic potential.
  • A total of 22.5% of children diagnosed with mycoplasma pneumonia exhibited drug-resistance gene mutations associated with elevated MP antibody levels.
  • Findings suggest that measuring MP antibody and procalcitonin can inform treatment decisions for pediatric patients with mycoplasma pneumonia.

Cite This Study

Zhang et al. (2025) studied this question.

synapsesocial.com/papers/68c23f1fb210217d64795373https://doi.org/10.1186/s12890-025-03870-z
View Full Paper
Ask AI
Bookmark
Share